DIASORIN

DIASORIN specializes in the provision of advanced diagnostic testing solutions and laboratory instrumentation. Their core capabilities include the delivery of QFT-TB assays for tuberculosis screening and VPD IGG testing for vaccine-preventable diseases. Additionally, the company provides technical infrastructure and maintenance through specialized service agreements for the LIAISON XL diagnostic platform. The company maintains a consistent relationship with the Department of Health, where they serve as a recurring provider of diagnostic assays and laboratory equipment service agreements. Their work focuses on supporting public health screening and diagnostic capabilities through multi-year procurement cycles. The company is positioned within the medical diagnostics and laboratory services vertical, focusing on the supply of specialized reagents and the maintenance of automated immunoassay systems. Based in Stillwater, Minnesota, the company operates as a government contractor providing critical diagnostic tools and technical support to health agencies.